US2019317016A1PendingUtilityA1

Spectroscopic analyser

Assignee: KLEIN MEDICAL LTDPriority: Apr 6, 2011Filed: Feb 6, 2019Published: Oct 17, 2019
Est. expiryApr 6, 2031(~4.7 yrs left)· nominal 20-yr term from priority
G01N 2201/0691G01N 21/84G01J 3/10G01N 21/3577G01J 3/42G01N 2201/0612G01J 2003/1286G01N 2021/3595G01N 21/359G01J 3/28G01J 3/427
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An analyser 10 for identifying or verifying or otherwise characterising a liquid based drug sample 16 comprising: an electromagnetic radiation source 11 for emitting electromagnetic radiation 14a in at least one beam at a sample 16, the electromagnetic radiation comprising at least two different wavelengths, a sample detector 17 that detects affected electromagnetic radiation resulting from the emitted electromagnetic radiation affected by the sample, and a processor 18 for identifying or verifying the sample from the detected affected electromagnetic radiation, wherein each wavelength or at least two of the wavelengths is between substantially 1300 nm and 2000 nm, and each wavelength or at least two of the wavelengths is in the vicinity of the wavelength(s) of (or within a region spanning) a spectral characteristic in the liquid spectrum between substantially 1300 nm and 2000 nm.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An analyser for identifying or verifying or otherwise characterising a liquid based drug sample comprising:
 an electromagnetic radiation source for emitting electromagnetic radiation comprising at least two different wavelengths,   a sample detector that detects affected electromagnetic radiation resulting from the emitted electromagnetic radiation affected by the sample, and   a processor for identifying or verifying the sample from the detected affected electromagnetic radiation,   wherein each wavelength or at least two of the wavelengths is between substantially 1300 nm and 2000 nm, and each wavelength or at least two of the wavelengths is in the vicinity of the wavelength(s) of (or within a region spanning) a spectral characteristic in the liquid spectrum between substantially 1300 nm and 2000 nm.

Join the waitlist — get patent alerts

Track US2019317016A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.